UK markets closed

Kala Pharmaceuticals, Inc. (KALA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.30+0.11 (+1.78%)
At close: 04:00PM EDT
6.75 +0.45 (+7.14%)
After hours: 06:10PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
3,892
11,240
6,362
Cost of revenue
0
0
2,560
4,097
3,173
Gross profit
0
0
1,332
7,143
3,189
Operating expenses
Research development
18,586
18,586
17,653
11,515
18,352
Selling general and administrative
20,567
20,567
65,035
105,061
81,068
Total operating expenses
34,328
34,328
82,688
116,576
99,420
Operating income or loss
-34,328
-34,328
-81,356
-109,433
-96,231
Interest expense
5,814
5,814
7,266
8,380
8,589
Total other income/expenses net
-4,768
-4,768
43,136
-24,896
-
Income before tax
-42,199
-42,199
-44,822
-142,605
-104,327
Income from continuing operations
-42,199
-42,199
-44,822
-142,605
-104,327
Net income
-42,199
-42,199
-44,822
-142,605
-104,327
Net income available to common shareholders
-42,199
-42,199
-44,822
-142,605
-104,327
Basic EPS
-22.38
-
-29.48
-108.32
-99.50
Diluted EPS
-22.38
-
-29.48
-108.32
-99.50
Basic average shares
2,156
-
1,521
1,316
1,048
Diluted average shares
2,156
-
1,521
1,316
1,048